We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

This study has been withdrawn prior to enrollment.
(insufficient enrollment)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01170052
First Posted: July 27, 2010
Last Update Posted: March 16, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Wyeth is now a wholly owned subsidiary of Pfizer
Mundipharma K.K.
Information provided by:
Charite University, Berlin, Germany
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)